Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study.

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 10037-10037 ◽  
Author(s):  
H. Gelderblom ◽  
J. Blay ◽  
B. M. Seddon ◽  
M. Leahy ◽  
I. L. Ray-Coquard ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Bone Sarcoma ◽  
First Line ◽  
Randomized Phase Ii ◽  
Metastatic Soft Tissue Sarcoma ◽  
Line Chemotherapy

Phase II study of liposomal daunorubicin and ifosfamide (IDx) as first line chemotherapy in soft tissue sarcoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9011-9011
Author(s):  
P. M. Deckert ◽  
J. M. Siehl ◽  
E. Thiel ◽  
A. Schmittel ◽  
G. Hütter ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
Liposomal Daunorubicin ◽  
Line Chemotherapy

Phase II study of liposomal daunorubicin and ifosfamide (IDx) as first line chemotherapy in soft tissue sarcoma

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 9011-9011
Author(s):  
P. M. Deckert ◽  
J. M. Siehl ◽  
E. Thiel ◽  
A. Schmittel ◽  
G. Hütter ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
Liposomal Daunorubicin ◽  
Line Chemotherapy
Sign in / Sign up

Export Citation Format

Share Document